In conclusion, this study for the first time demonstrates that Cholecalciferol improves endothelial vasomotor and secretory function, in stable non-diabetes stage 3/4 CKD patients without any significant effect on arterial stiffness, calcium and FGF-23 levels. The gene discussed is FGF23; the disease is diabetes mellitus.